Study title: Open-Label Evaluation of 5% 5. Benzoyl Peroxide/1% Clindamycin Gel used in combination with Tazarotene 0.1% Cream and Oral Minocycline in the treatment of severe acne vulgaris.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Skin and Connective Tissue Diseases [C17] | |||||
| Brands: Please see report, Please see report | |||||
| MAH holders: Please see report, Please see report | |||||
| Assessment: | |||||
| Active substance: BENZOYLPEROXIDE AND CLINDAMYCIN | |||||
| ATC code: D10A X30 | |||||
| Document link: Article 45_Ref_U0515_Final for Submission_09Nov2011.xlsx | |||||
| Document date: 2013-11-11 | |||||
| Study number: UO515 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | - | |